Pacira BioSciences (PCRX) Change in Account Payables (2010 - 2026)

Pacira BioSciences' Change in Account Payables history runs 12 years deep, the most recent figure standing at -$936000.0 for Q1 2026.

• In Q1 2026, Change in Account Payables fell 137.99% year-over-year to -$936000.0; the TTM figure through Mar 2026 stood at -$9.0 million (down 171.85% YoY), while the FY2025 annual figure was -$5.6 million, down 281.52% from the prior year.
• Change in Account Payables was -$936000.0 for Q1 2026 at Pacira BioSciences, up from -$2.9 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $9.7 million in Q2 2024 to a low of -$12.0 million in Q3 2025.
• Historically, Change in Account Payables has averaged $219882.4 across 5 years, with a median of -$325000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Account Payables soared 932.94% in 2023, then tumbled 1985.87% in 2025.
• A 5-year view of Change in Account Payables shows it stood at $1.6 million in 2022, then slumped by 167.38% to -$1.1 million in 2023, then jumped by 69.68% to -$325000.0 in 2024, then slumped by 801.23% to -$2.9 million in 2025, then soared by 68.04% to -$936000.0 in 2026.
• The last three Change in Account Payables figures came in at -$936000.0 (Q1 2026), -$2.9 million (Q4 2025), and -$12.0 million (Q3 2025), per Business Quant data.